Sector ratings Perspective Therapeutics, Inc.

Stocks

Market Closed - NYSE Other stock markets 21:00:00 23/07/2026 BST			5-day change	1st Jan Change
2.950 ^USD	-0.67%		0.00%	+7.27%

07-17	Perspective Therapeutics Data On 212Pb VMT-a-NET Accepted For Oral Presentation At ESMO Congress 2026	CI
07-08	Perspective Therapeutics, Inc. Announces Executive Changes	CI

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Global Valuation
PERSPECTIVE THERAPEUTICS, INC.	339M	-	BBB	-	-
LONZA GROUP AG	46.06B		AAA
REVOLUTION MEDICINES, INC.	38.91B	-	B	-	-
BEONE MEDICINES AG	35.57B		-
IQVIA HOLDINGS INC.	33.13B		AAA
CELLTRION, INC.	26.42B		A
ASCENDIS PHARMA A/S	16.61B	-	-	-	-
MEDPACE HOLDINGS, INC.	15.08B		BBB
EUROFINS SCIENTIFIC SE	14.08B		AA
ICON PUBLIC LIMITED COMPANY	12.81B		AAA
ABIVAX	11.35B	-	BBB	-	-
BIO-TECHNE CORPORATION	11.19B		AA
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	10.53B		AA
APOGEE THERAPEUTICS, INC.	10.07B	-	B	-	-
PHARMARON BEIJING CO., LTD.	9.77B		AA
KYMERA THERAPEUTICS, INC.	9.08B	-	BBB	-	-
IONIS PHARMACEUTICALS, INC.	8.93B	-	A	-	-
ALKERMES PLC	8.76B		A
PROTAGONIST THERAPEUTICS, INC.	8.71B		BB		-
PRAXIS PRECISION MEDICINES, INC.	8.7B	-	B	-	-
Average	16.8B		A
Weighted average by Cap.			A

×